PhD, PEng. â€“ CEO and Founder
Nima has over 15 years of experience in entrepreneurship, business development, project management, and development of machine vision, robotics, and embedded systems for the mining, automotive, residential, and clinical sectors. He is a Professional Engineer (P.Eng.) with a scientific background in electrical and computer engineering. Since the creation of TIPSOTM in 2013, through his leadership role at NZTech, he has been able to secure nearly $2M of private and non-diluted funding to support R&D, experimental developments, and the commercialization of TIPSOTM.
B.A.Sc. â€“ Director of Engineering
Pranav has a B.A.Sc. in engineering physics, with specialization in electrical engineering, from UBC. He has over 7 years of experience in development of embedded hardware, machine vision, and robotics for the arts, assisted living, residential, and clinical sectors. Pranav joined NZTech to build the first TIPSOTM prototypes from early R&D and now directs all of the teamâ€™s engineering activities.
Ph.D. â€“ VP of Sales and Marketing
David has over 14 years of experience working with a variety of medical technologies in different capacities, focused on sales and marketing of medical devices for cardiovascular interventions, neurosurgery, orthopaedics and wound repair. He has held leadership roles in market development and channel management in the U.S., Asia Pac, and other international regions. He joined NZTech with the primary responsibility of driving the commercial growth of TIPSOTM. David completed his Ph.D. in Biomedical Engineering from Northwestern University and postdoctoral qualification from Mount Sinai School of Medicine.
MD, BASc, FRCPC â€“ Medical Advisor
Dr. Behrang Homayoon graduated with distinction from the UBC department of electrical engineering, completed his medical and radiology residency training at UBC followed by fellowship training in vascular and interventional radiology at the world-renowned Miami Cardiac and Vascular Institute. He is currently the head of interventional radiology at Surrey Memorial Hospital.
MD, FRCPC FSIR â€“ Clinical Advisor
Dr. Liu is an Interventional Radiologist and the Associate Professor of Radiology at UBC. He holds appointments at VGH, UBC Hospital, and the BC Cancer Agency. He is active in clinical research in novel embolic platforms, and cancer related thromboembolic disease.
MD, FRCPC â€“ Clinical Advisor
Dr. Chung is an Interventional Radiologist and Clinical Instructor of Radiology at UBC. He is the director of the UBC Interventional Radiology Fellowship Program. He holds clinical appointments at VGH and UBC Hospital.
MD, â€“ Clinical Advisor
Dr. Bond is the Chief of Thoracic Surgery at Surrey Memorial Hospital. He has led the adoption of the MATRIX thoracic surgical procedure and created a comprehensive program of care at Surrey Memorial Hospital. He has led a Rapid Autopilot Program to speed up lung cancer wait times from an average of 190 days to 45 days.
Prof. Peter Lawrence is a Professor Emeritus in the UBC ECE Department with long-standing research interests and publications in human interface devices and their evaluation. He has relevant experience in image processing, eye/gaze tracker design, mobile machine hand-control design, machine motion simulators, and human coordinated control.
Investor â€“ Board of Directors
Terry is an experienced executive in the life sciences sector, with a focus on business development and finance. Most recently he was part of the senior management team at Coastal Contacts, a world leading optical company that was acquired by Essilor International for $430 million. He is the President of ZT Capital Inc., which focuses on investing in early stage companies and assisting in their growth.
Investor â€“ Board of Directors
Shahram has over 25 years of experience in entrepreneurship and technology innovation. Shahram is the Founder and CEO at Motion Metrics Int. with products that have revolutionized safety and productivity in mining environments.
Investor â€“ Business Advisor
Mark has a keen interest in early stage growth companies. Companies he has invested in cover a broad range of technologies, including health and life sciences. Mark has an MBA from the Stanford Graduate School of Business, Class of 1980.
David Christie is an experienced executive with a proven ability to commercialize innovative technology. He is the founder and current president of Christie Consulting Services, and an executive-in-residence at Wavefront AC.